Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-CSF in Neonates With Neutropenia and Sepsis
NCT07888829Not yet recruiting
- Sponsor
- University of Health Sciences Lahore
- Start
- Feb 2027
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
Randomised trial of granulocyte colony-stimulating factor in neonatal sepsis and neutropenia (2 arms), sponsored by University of Health Sciences Lahore. Primary endpoint: Mortality at 28 days. Planned start Feb 2027; status: not yet recruiting.
02
Drugs
granulocyte colony-stimulating factor
03
Conditions
neonatal sepsisneutropenia
Beyond the preview
Go deeper on NCT07888829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07888829.